BPTH Bio-Path Holdings, Inc.

0.41
-0.0035  -1%
Previous Close 0.41
Open 0.44
Price To book 4.84
Market Cap 39.05M
Shares 95,645,000
Volume 116,809
Short Ratio 24.90
Av. Daily Volume 174,838

SEC filingsSee all SEC filings

  1. 8-K - Current report 17859675
  2. 8-K - Current report 17832540
  3. 10-Q - Quarterly report [Sections 13 or 15(d)] 17830966
  4. 8-K - Current report 17764146
  5. 8-K - Current report 17742207

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 first patient enrolled November 2016. Interim analysis due by the end of 2017.
BP-1001
Acute myeloid leukemia (AML)

SEC Filings

  1. 8-K - Current report 17859675
  2. 8-K - Current report 17832540
  3. 10-Q - Quarterly report [Sections 13 or 15(d)] 17830966
  4. 8-K - Current report 17764146
  5. 8-K - Current report 17742207
  6. 8-K - Current report 17689820
  7. 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] 17689796
  8. 8-K - Current report 17681972
  9. 8-K - Current report 17675265
  10. 8-K - Current report 17625412